Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Wilson

Showing results (191-200 of 1,176) with videos related to

Pageof 118
Sort By:
JACC. Basic to Translational Science|November 13, 2024
Targeting Mitochondria Dysfunction in LMNA CardiomyopathyChia-Feng Liu, W H Wilson Tang
European Journal of Heart Failure|April 28, 2016
Endothelin-1 is independently associated with 180-day mortality after adjusting for body mass indexAntonio L Perez, W H Wilson Tang
Circulation. Heart Failure|December 25, 2015
Assessing Impedance in Heart Failure: From Device Diagnostics to Population Health Opportunities?Roy S Small, W H Wilson Tang
Journal of the American College of Cardiology|January 22, 2003
Spironolactone in chronic heart failure:all's well that ends wellW H Wilson Tang, Gary S Francis
Journal of Cardiac Failure|December 18, 2013
Heart failure notwithstanding ejection fraction (HFnEF)--a possible unifying hypothesis?Mark E Dunlap, W H Wilson Tang
Journal of the American College of Cardiology|April 20, 2005
Should we consider aldosterone as the primary screening target for preventing cardiovascular events?Gary S Francis, W H Wilson Tang
Reviews in Cardiovascular Medicine|May 31, 2003
Pathophysiology of congestive heart failureGary S Francis, W H Wilson Tang
Nature Reviews. Cardiology|March 18, 2010
Statin treatment for patients with heart failureW H Wilson Tang, Gary S Francis
Journal of the American College of Cardiology|December 11, 2007
The year in heart failureW H Wilson Tang, Gary S Francis
Current Cardiology Reports|April 13, 2004
Evolving concepts in left ventricular systolic and diastolic remodeling: implications for therapyW H Wilson Tang, Gary S Francis
Pageof 118

Showing results (191-200 of 1,176) with videos related to

Sort By:
Pageof 118
JACC. Basic to Translational Science|November 13, 2024
Targeting Mitochondria Dysfunction in LMNA CardiomyopathyChia-Feng Liu, W H Wilson Tang
European Journal of Heart Failure|April 28, 2016
Endothelin-1 is independently associated with 180-day mortality after adjusting for body mass indexAntonio L Perez, W H Wilson Tang
Circulation. Heart Failure|December 25, 2015
Assessing Impedance in Heart Failure: From Device Diagnostics to Population Health Opportunities?Roy S Small, W H Wilson Tang
Journal of the American College of Cardiology|January 22, 2003
Spironolactone in chronic heart failure:all's well that ends wellW H Wilson Tang, Gary S Francis
Journal of Cardiac Failure|December 18, 2013
Heart failure notwithstanding ejection fraction (HFnEF)--a possible unifying hypothesis?Mark E Dunlap, W H Wilson Tang
Journal of the American College of Cardiology|April 20, 2005
Should we consider aldosterone as the primary screening target for preventing cardiovascular events?Gary S Francis, W H Wilson Tang
Reviews in Cardiovascular Medicine|May 31, 2003
Pathophysiology of congestive heart failureGary S Francis, W H Wilson Tang
Nature Reviews. Cardiology|March 18, 2010
Statin treatment for patients with heart failureW H Wilson Tang, Gary S Francis
Journal of the American College of Cardiology|December 11, 2007
The year in heart failureW H Wilson Tang, Gary S Francis
Current Cardiology Reports|April 13, 2004
Evolving concepts in left ventricular systolic and diastolic remodeling: implications for therapyW H Wilson Tang, Gary S Francis
Pageof 118